Dr. Jun Zhang is a medical oncologist, physician, and scientist at KU Medical Center of the University of Kansas in Kansas City. He is passionate about both patient care and research, working to carry scientific discoveries to the bedsides of patients diagnosed with lung cancer, malignant pleural mesothelioma, and other thoracic malignancies. Dr. Zhang serves
Dr. Linda Garland is a thoracic medical oncologist at the University of Arizona Banner Health. She has expertise in lung cancer and malignant pleural mesothelioma and is particularly interested in the use of experimental therapeutics to improve patient outcomes. Education and Career Dr. Garland earned her medical degree at the University of Texas Health Science Center.
Dr. Helen J. Ross is a medical oncologist who specializes in the treatment of lung cancers of all types, including malignant pleural mesothelioma, at RUSH University Cancer Center in Chicago, Illinois. In addition to her role as professor of Internal Medicine, Oncology and as Interim Chief of the Division of Hematology, Oncology, and Cellular Therapy,
Dr. Evan Osmundson is a radiation oncologist specializing in lung cancer, mesothelioma, and thoracic cancers at Vanderbilt University Medical Center in Nashville, Tennessee. He is highly skilled in the use of innovative radiation treatments, including, 3D conformal radiation, adaptive radiotherapy, Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiotherapy, Stereotactic Radiosurgery, Total Body Radiation, and Total Skin
Dr. Andreas Saltos is a board-certified medical oncologist at the Moffitt Cancer Center in Tampa, Florida. He specializes in treating patients with thoracic malignancies, including those diagnosed with malignant pleural mesothelioma and all types of lung cancer, at all stages. His treatment approach is centered on identifying the most appropriate treatment protocol to meet his
Dr. Jeffrey P. Ward is a physician-scientist at the Siteman Cancer Center and Washington University School of Medicine with a particular interest in thoracic oncology. His patient care is focused on treating patients diagnosed with lung cancer and other thoracic malignancies. He works to leverage innovations, including immunotherapy treatments, to develop better strategies that arm
Dr. Mark A. Socinski is a medical oncologist and Executive Director of the AdventHealth Cancer Institute in Orlando, Florida. He specializes in thoracic malignancies including pleural mesothelioma and non-small and small cell lung cancers and is an internationally recognized expert in the development of novel chemotherapy agents and treatment strategies for those diseases. Education and
Dr. Thomas E. Stinchcombe is a medical oncologist at the Duke Cancer Institute and a Professor of Medicine at the Duke School of Medicine in Durham, North Carolina. He specializes in the treatment of thoracic malignancies, including small and non-small cell lung cancer and malignant pleural mesothelioma. Dr. Stinchcombe is actively involved in the development
Dr. Ramesh Rengan is a radiation oncologist at the University of Washington and Fred Hutch Cancer Center. He specializes in radiation treatment of lung cancer and thoracic malignancies including pleural mesothelioma, as well as melanoma, ocular tumors, renal cell carcinoma, and prostate cancer. In addition to treating patients using innovative radiation tools, Dr. Rengan oversees
Dr. Craig Stevens is a radiation oncologist specializing in treating patients with lung cancer and malignant pleural mesothelioma at Beaumont Health in Royal Oaks, Michigan (now known as Corewell Health). He holds the title of System Chair of Radiation Oncology for Beaumont Health, as well as Department Chair and Professor of Radiation Oncology at Oakland